REFERENCES
- Medawar P B. A second study of the behavior and fate of skin homografts in rabbits. (A report to the War Wounds Committee of the Medical Research Council). J Anat 1945; 79: 157–188
- Medawar P B. Immunity to homologous grafted skin. III. The fate of skin homografts transplanted to the brain, to subcutaneous tissue and to the anterior chamber of the eye. Br J Exp Pathol 1948; 29: 58–69
- Stein-Streilein J, Streilein J W. Anterior chamber associated immune deviation (ACAID); regulation, biological relevance, and implications for therapy. Int Rev Immunol 2002; 21: 123–152, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Streilein J W. Ocular immune privilege: therapeutic opportunities from an experiment of nature. Nat Rev Immunol 2003; 3: 879–889, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Kaplan H J, Streilein J W. Immune response to immunization via the anterior chamber of the eye. J Immunol 1997; 118: 809–814
- Streilein J W, Niederkorn J Y. Induction of anterior chamber-associated immune deviation requires an intact, functional spleen. J Exp Med 1981; 153: 1058–1067, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Wilbanks G A, Streilein J W. Studies on the induction of anterior chamber-associated immune deviation (ACAID). I. Evidence that an antigen-specific, ACAID-inducing, cell-associated signal exists in the peripheral blood. J Immunol 1991; 146: 2610–2617, [PUBMED], [INFOTRIEVE]
- Hara Y, Caspi R R, Wiggert B, Dorf M, Streilein J W. Analysis of an in vitro-generated signal that induces systemic immune deviation similar to that elicited by antigen injected into the anterior chamber of the eye. J Immunol 1992; 149: 1531–1538, [PUBMED], [INFOTRIEVE]
- Wilbanks G A, Mammolenti M, Streilein J W. Studies on the induction of anterior chamber-associated immune deviation (ACAID). III. Induction of ACAID depends upon intraocular transforming growth factor-beta. Eur J Immunol 1992; 22: 165–173, [PUBMED], [INFOTRIEVE], [CSA]
- D'Orazio T J, Niederkorn J Y. Splenic B cells are required for tolerogenic antigen presentation in the induction of anterior chamber-associated immune deviation (ACAID). Immunology 1998; 95: 47–55, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Sonoda K-H, Exley M, Snapper S, Balk S, Stein-Streilein J. CD1 reactive NKT cells are required for development of systemic tolerance through an immune privileged site. J Exp Med 1999; 190: 1215–1225, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Taniguchi M, Harada M, Koyo S, Nakayama T, Wakao H. The regulatory role of Vα 14 NKT cells in innate and acquired immune response. Annu Rev Immunol 2003; 21: 483–513, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Bendelac A. Mouse NK1+ T cells. Curr Opin Immunol 1995; 7: 367–374, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Yoshimoto T, Paul W E. CD4+, NK1.1+ T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3. J Exp Med 1994; 179: 1285–1295, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Yoshimoto T, Bendelac A, Watson C, Hu-Li J, Paul W E. Role of NK1.1+ T cells in a TH2 response and in immunoglobulin E production. Science 1995; 270: 1845–1847, [PUBMED], [INFOTRIEVE]
- Godfrey D I, Hammond K J, Poulton L D, Smyth M J, Baxter A G. NKT cells: facts, functions and fallacies. Immunol Today 2000; 21: 573–583, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Lantz O, Bendelac A. An invariant T cell receptor alpha chain is used by a unique subset of major histocompatibility complex class I-specific CD4+ and CD4−8− T cells in mice and humans. J Exp Med 1994; 180: 1097–1106, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Bendelac A, Rivera M N, Park S H, Roark J H. Mouse CD1-specific NK1 T cells: development, specificity, and function. Annu Rev Immunol 1997; 15: 535–562, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- MacDonald H R. Development and selection of NKT cells. Curr Opin Immunol 2002; 14: 250–254, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Vicari A P, Herbelin A, Leite-de-Moraes M, Von Freeden-Jeffrey U, Murray R, Zlotnik A. NK1.1+ T cells from IL-7-deficient mice have a normal distribution and selection but exhibit impaired cytokine production. Int Immunol 1996; 8(11)1759–1766, [PUBMED], [INFOTRIEVE]
- Ohteki T, Ho S, Suzuki H, Mak T W, Ohashi P S. Role for IL-15/IL-15 receptor β -chain in natural killer 11+ T cell receptor-α β+ cell development. J Immunol 1997; 159: 5931–5935, [PUBMED], [INFOTRIEVE]
- Iizuka K, Chaplin D D, Wang Y, et al. Requirement for membrane lymphotoxin in natural killer cell development. Proc Natl Acad Sci USA 1999; 96: 6336–6340, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Elewaut D, Brossay L, Santee S M, et al. Membrane lymphotoxic is required for the development of different subpopulations of NK T cells. J Immunol 2000; 165: 671–679, [PUBMED], [INFOTRIEVE]
- Eberl G, Fehling H J, von Boehmer H, MacDonald H R. Absolute requirement for the pre-T cell receptor α chain during NK1.1+ TCR α β cell development. Eur J Immunol 1999; 29: 1966–1971, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Sato H, Nakayama T, Tanaka Y, et al. Induction of differentiation of pre-NKT cells to mature Vα 14 NKT cells by granulocyte/macrophage colony-stimulating factor. Proc Natl Acad Sci 1999; 96: 7439–7444, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Eberl G, Lowin-Kropf B, MacDonald H R. Cutting edge: NKT cell development is selectively impaired in Fyn-deficient mice. J Immunol 1999; 163: 4091–4094, [PUBMED], [INFOTRIEVE]
- Gadue P, Morton N, Stein P L. The Src family tyrosine kinase Fyn regulated natural killer T cell development. J Exp Med 1999; 190: 1189–1195, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Benlagha K, Weiss A, Beavis A, Teyton L, Bendelac A. In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers. J Exp Med 2000; 191: 1895–1903, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Burdin N, Kronenberg M. CD1-mediated immune responses to glycolipids. Curr Opin Immunol 1999; 11: 326–331, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Joyce S, Woods A S, Yewdell J W, et al. Natural ligand of mouse CD1d1: cellular glycosylphosphatidylinositol. Science 1998; 279: 1541–1544, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Schofield L, McConville M J, Hansen D, et al. CD1d-restricted immunoglobulin G formation to GPI-anchored antigens mediated by NKT cells. Science 1999; 283: 225–229, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Apostolou I, Takahama Y, Belmant C, et al. Murine natural killer cells contribute to the granulomatous reaction caused by mycobacterial cell walls. Proc Natl Acad Sci 1999; 96: 5141–5146, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Hong S, Scherer D C, Singh N, et al. Lipid antigen presentation in the immune system: lessons learned from CD1d knockout mice. Immunol Rev 1999; 169: 31–44, [PUBMED], [INFOTRIEVE], [CSA]
- Singh N, Hong S, Scherer D C, et al. Cutting edge: Activation of NK T cells by CD1d and α -galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype. J Immunol 1999; 163: 2373–2377, [PUBMED], [INFOTRIEVE]
- Hara Y, Okamoto S, Rouse B, Streilein J W. Evidence that peritoneal exudate cells cultured with exe-derivedhinds are the proximate antigen presenting cells in immune deviation of the ocular type. J Immunol 1993; 151: 5102–5171
- Sonoda K-H, Faunce D E, Taniguchi M, Exley M, Balk S, Stein-Streilein J. NKT cell-derived IL-10 is essential for the differentiation of antigen-specific T regulatory cells in systemic tolerance. J Immunol 2001; 166: 42–50, [PUBMED], [INFOTRIEVE]
- Faunce D E, Stein-Streilein J. NKT cell-derived RANTES recruits APCs and CD8+ T cells to the spleen during the generation of regulatory T cells in tolerance. J Immunol 2002; 169: 31–38, [PUBMED], [INFOTRIEVE]
- Kosiewicz M M, Alard P, Streilein J A. Alterations in cytokine production following intraocular injection of soluble protein antigen: impairment of IFNgamma and induction of TGFbeta and IL-4 production. J. Immunol. 1998; 161: 5382–5390, [PUBMED], [INFOTRIEVE]
- Faunce D E, Sonoda K-H, Stein-Streilein J. MIP-2 recruits NKT cells to the spleen during tolerance induction. J Immunol 2001; 166: 313–321, [PUBMED], [INFOTRIEVE]
- Förster R, Schubel A, Breitfeld D, et al. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 1999; 99: 23–33, [CROSSREF]
- Potsch C, Vöhringer D, Pircher H. Distinct migration patterns of naive and effector CD8 T cells in the spleen: correlation with CCR7 receptor expression and chemokine reactivity. Eur J Immunol 1999; 29: 3562–3570, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Sonoda K-H, Stein-Streilein J. CD1d on antigen-transporting APC and splenic marginal zone B cells promotes NKT cell-dependent tolerance. Eur J Immunol 2002; 32: 848–857, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Zeng D, Lewis D, Dejbakhsh-Jones S, et al. Bone marrow NK1.1(−) and NK1.1(+) T cells reciprocally regulate acute graft versus host disease. J Exp Med 1999; 189: 1073–1081, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Shao H, Van Kaer L, Sun S L, Kaplan H J, Sun D. Infiltration of the inflamed eye by NKT cells in a rat model of experimental autoimmune uveitis. J Autoimmun 2003; 21: 37–45, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Sano Y, Okamoto S, Streilein J W. Induction of donor-specific ACAID can prolong orthotopic corneal allograft survival in ‘high risk’ eyes. Curr Eye Res. 1997; 16: 1171–1174, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Sonoda K-H, Taniguchi M, Stein-Streilein J. Long-term survival of corneal allografts is dependent on intact CD1d-reactive NKT cells. J Immunol 2002; 168: 2028–2034, [PUBMED], [INFOTRIEVE]
- Zhang B, Yamamura T, Kondo T, Fujiwara M, Tabira T. Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells. J Exp Med 1997; 186: 1677–1687, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Faunce D E, Gamelli R L, Choudhry M A, Kovacs E J. A role for CD1d-restricted NKT cells in injury-associated T cell suppression. J Leukocyte Biol 2003; 73: 747–755, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Lisbonne M, Diem S, de Castro Keller A, et al. Cutting edge: Invariant Vα 14 NKT cells are required for allergen-induced airway inflammation and hyperreactivity in an experimental asthma model. J Immunol 2003; 171: 1637–1641, [PUBMED], [INFOTRIEVE]
- Akbari O, Stock P, Meyer E, et al. Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity. Nat Med 2003; 9: 582–588, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Korsgren M, Persson C GA, Sundler F, et al. Natural killer cells determine development of allergen-induced eosinophilic airway inflammation in mice. J Exp Med 1999; 189: 553–562, [PUBMED], [INFOTRIEVE]
- Campos R A, Szczepanik M, Itakura A, Akahira-Azuma M, Sidobre S, Kronenberg M. Cutaneous immunization rapidly activates liver invariant Vα 14 NKT cells stimulating B-1 B cells to initiate T cell recruitment for elicitation of contact sensitivity. J Exp Med 2003; 198: 1779–1783
- Dieli F, Taniguchi M, Asherson G L, et al. Development of hapten-induced IL-4-producing CD4+ T lymphocytes requires early IL-4 production by α β T lymphocytes carrying invariant Vα 14 TCR α chains. Int Immunol 1998; 10: 413–420, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Sumida T, Sakamoto A, Murata H, et al. Selective reduction of T cells bearing invariant Vα 24JαQ antigen receptor in patients with systemic sclerosis. J Exp Med 1995; 182: 1163–1168, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Shivakumar S, Tsokos G C, Datta S K. T cell receptor α β expressing double-negative (CD4−/CD8−) and Cd4+ T helper cells in humans augment the production of pathogenic anti-DNA autoantibodies associated with lupus nephritis. J Immunol 1989; 143: 103–112, [PUBMED], [INFOTRIEVE]
- Gombert J M, Herbelin A, Tancrede-Bohin E, Dy M, Carnaud C, Bach J F. Early quantitative and functional deficiency of NK1+-like thymocytes in the NOD mouse. Eur J Immunol 1996; 26: 2989–2998, [PUBMED], [INFOTRIEVE], [CSA]
- Godfrey D I, Kinder S J, Silvera P, Baxter A G. Flow cytometric study of T cell development in NOD mice reveals a deficiency in α β TCR+CDR−CD8− thymocytes. J Autoimmun 1997; 10: 279–285, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Illes Z, Kondo T, Newcombe J, Oka N, Tabira T, Yananura T. Differential expression of NK T cell Valpha24JalphaQ invariant TCR chain in the lesions of multiple sclerosis and chronic inflammatory demyelinating polyneuropathy. J Immunol 2000; 164: 4375–4381, [PUBMED], [INFOTRIEVE]
- Gausling R, Trollmo C, Hafter D. Decreases in interleukin-4 secretion by invariant CD4-CD8- Va24jaQT cells in peripheral blood of patients with relapsing-remitting multiple sclerosis. Clin Immunol 2001; 98: 11–17, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Kawamura T, Takeda K, Mendiratta S K, et al. Cutting edge: Critical role of NK1+ T cells in IL-12-induced immune responses in vivo. J Immunol 1998; 160: 16–19, [PUBMED], [INFOTRIEVE]
- Hashimoto W, Takeda K, Anzai R, et al. Cytotoxic NK1.1 Ag+α β T cells with intermediate TCR induced in the liver of mice by IL-12. J Immunol 1995; 154: 4333–4340, [PUBMED], [INFOTRIEVE]
- Cui J, Shin T, Kawano T, et al. Requirement for Vα 14 NKT cells in IL-12-mediated rejection of tumors. Science 1997; 278: 1623–1626, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Eberl G, MacDonald H R. Selective induction of NK cell proliferation and cytotoxicity by activated NKT cells. Eur J Immunol 2000; 30: 985–992, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Kawano T, Cui J, Koezuka Y, et al. Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Valpha14 NKT cells. Proc Natl Acad Sci USA 1998; 95: 5690–5693, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Carnaud C, Lee D, Donnars O, et al. Cutting edge: cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells. J Immunol 1999; 163: 4647–4650, [PUBMED], [INFOTRIEVE]
- Terabe M, Matsui S, Noben-Trauth N, et al. NKT cell mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway. Nat Immunol 2000; 1: 515–520, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Dunn G P, Bruce A T, Ikeda H, Old L J, Schreiber R D. Cancer immunoediting: from immuno-surveillance to tumor escape. Nat Immunol 2002; 3: 991–998, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Crowe N Y, Smyth M J, Godfrey D I. A critical role for natural killer T cells in immunosurveillance of methylcholanthrene-induced sarcomas. J Exp Med 2002; 196: 119–127, [PUBMED], [INFOTRIEVE], [CROSSREF]